NewMed Energy cancels USD 6.70 billion deal as NewMed Energy stock faces a dispute
Published on 10/15/2026 at 11:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSContract and operating figures
- NewMed Energy canceled the USD 6.70 billion agreement on October 8, 2026.
- Second-quarter gas and condensate sales rose 52.90 percent to USD 293.20 million.
- NewMed Energy is scheduled to report earnings on November 12, 2026.
NewMed Energy (ISIN IL0004750209) canceled a USD 6.70 billion gas supply agreement covering 20 years on October 8, 2026. The Jerusalem Post reported that Dalia Energy rejected the cancellation and said it intended to pursue its legal rights.
Three dates define the dispute
On September 24, 2026, NewMed and its partner Ratio notified Dalia that the agreement was terminated, according to The Jerusalem Post. On October 7, 2026, Globes reported that NewMed maintained the cancellation despite regulatory approval, while Dalia said the agreement remained in force. On October 8, 2026, NewMed and Ratio again announced the cancellation, putting the USD 6.70 billion contract at the center of the stock story.
What does the 45.30 percent stake mean?
NewMed's operating base remains the Leviathan field, where it holds a 45.30 percent working interest, according to the company's investor-relations page. That exposure gives the canceled contract strategic importance, but the latest operating figures show a mixed picture. Gas and condensate sales rose 52.90 percent year over year to USD 293.20 million in the second quarter of 2026, while first-half net profit fell 79.70 percent to USD 117.90 million, according to DeepTase. The contrast puts production and project execution alongside the contract dispute.
When is the next report?
NewMed Energy is scheduled to publish its next earnings report on November 12, 2026, according to TradingView. The date should provide the next formal update on production, cash generation and the commercial dispute.
Business facts for investors
NewMed Energy operates in offshore natural gas exploration, development and production, with assets linked to Israel and the eastern Mediterranean. Its investor-relations page lists the second-quarter 2026 report dated August 13, 2026 and identifies the partnership's Leviathan working interest at 45.30 percent.
NewMed Energy stock facts
- Company: NewMed Energy - Limited Partnership
- ISIN: IL0004750209
- Ticker: NWMD
- Primary exchange: Tel Aviv Stock Exchange
- Sector / Industry: Energy / Oil and gas exploration and production
Market context: Market report TA-35.
